In addition, ELOVL6 was inconsistent with the results of other researchers.They found that ELOVL6 enhanced oncogenic activity in liver cancer and indicated poor prognosis in patients with HCC, whereas the results of ours showed no significance (47). The gene discussed is ELOVL6; the disease is liver cancer.